AFINITOR
Analogs of AFINITOR
Find cheaper analogs and generic equivalents for AFINITOR.
Active Ingredient: EVEROLIMUS
Product Overview
About AFINITOR
AFINITOR is a prescription medicine used to treat certain types of cancer, including renal cell carcinoma (RCC) and neuroendocrine tumors (NETs) of pancreatic origin. It is also used to treat subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC), and to treat angiomyolipoma (AML) associated with TSC.
Key Benefits & Uses
- Treatment of renal cell carcinoma (RCC) in patients who have received prior treatment with other cancer therapies.
- Treatment of neuroendocrine tumors (NETs) of pancreatic origin in patients with progressive disease.
- Treatment of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC).
- Treatment of angiomyolipoma (AML) associated with tuberous sclerosis complex (TSC).
Active Ingredient & Action
AFINITOR contains the active ingredient everolimus, which is a mammalian target of rapamycin (mTOR) inhibitor. Everolimus works by blocking the action of mTOR, a protein that helps regulate cell growth and division. By inhibiting mTOR, everolimus can help slow the growth of cancer cells and reduce the size of tumors.
Important Notes
AFINITOR is available in tablet form and should be taken orally once daily. It is essential to follow the recommended dosage and administration instructions provided by your healthcare provider. AFINITOR can cause serious side effects, including lung or breathing problems, kidney failure, and increased risk of infections. It is crucial to discuss any medical history, current medications, and potential interactions with your healthcare provider before starting treatment with AFINITOR.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.